Father, US Marine and Interventional Radiologist with special interests in oncology and pain palliation. My Tweets are my own. Innovation=Interventional
At @MiamiSpectrum SPECTRUM2026, we presented our first reported SpyGlass-assisted biopsy-proven transductal pancreatic biopsy expanding the diagnostic reach of direct visualization techniques.@RajNarayanan67#Bostonsci@hsinghIR
📢 Exciting News: IR Centers at SIR 2025 Annual Scientific Meeting! 🎉
We’re thrilled to announce that four abstracts from IR Centers have been accepted for oral presentations at the upcoming SIR 2025 Annual Scientific Meeting in Nashville! This recognition highlights our ongoing commitment to advancing interventional radiology through cutting-edge research and innovation.
Here’s a preview of the impactful studies we’ll be presenting:
🔹 Embolization for Heel Pain Secondary to Plantar Fasciitis:
A pilot study using Lipiodol® as a novel embolic agent.
📅 April 2, 11:06–11:15 AM
🔹 Efficacy of Greater Trochanteric Bursitis Embolization:
For patients refractory to conservative therapy.
📅 April 2, 10:57–11:06 AM
🔹 Incidence of Major Complications from Prostatic Artery Embolization:
A multicenter experience of 9,000 procedures.
📅 April 2, 11:51 AM–12:00 PM
🔹 Hemorrhoidal Artery Embolization:
Long-term efficacy in symptomatic hemorrhoid treatment.
📅 April 1, 3:27–3:36 PM
A huge thank you to our incredible team for their dedication to these groundbreaking studies. We’re proud to lead the way in minimally invasive treatments and can’t wait to share our findings with the interventional radiology community in Nashville!
Stay tuned for updates as we continue to push the boundaries of innovation in IR.
#IRCenters #SIR2025 #InterventionalRadiology #Innovation #MedicalResearch #Embolization #MinimallyInvasive #PatientCare #Nashville @SIRspecialists@AriIsaacsonMD@AbinSajanMD@UsaProstate
Every year, @theNCI partners with @CDCgov, @AmericanCancer, and @NAACCR to produce the Annual Report to the Nation on the Status of Cancer.
This year’s report shows cancer deaths continued a downward trend between 2015-2019. #CancerAnnualReport https://t.co/JQSWqGgeV1
Lead-based shields will no longer be used during routine imaging exams for most patients at @DukeHealth clinics. @DukeRadiology experts share how “shedding the lead” will ensure safer imaging tests
https://t.co/1A3e9fAIw3